File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: In the Wireless Era: Leadless Pacing

TitleIn the Wireless Era: Leadless Pacing
Authors
KeywordsCardiac resynchronization therapy
Heart failure
Pacemaker
Ultrasound
Issue Date2010
PublisherFuture Drugs Ltd.. The Journal's web site is located at http://www.future-drugs.com/publication.asp?publicationid=2
Citation
Expert review of cardiovascular therapy, 2010, v. 18 n. 2, p. 171-174 How to Cite?
AbstractCardiac pacemakers have been the standard therapy for patients with bradyarrhythmias for several decades. The pacing lead is an integral part of the system that serves as a conduit for delivery of energy pulses to stimulate the myocardium. However, it is also an Achilles tendon that directly causes most device complications both acutely during implant and chronically years afterwards. Both durability and optimization of stimulation site are important areas of improvement for manufacturers and implanters. Elimination of the pacing lead and utilization of other means for energy transfer is the only way to avoid lead complications and allow better choice of stimulation site. Leadless pacing with ultrasound-mediated energy has been demonstrated in animals and humans in acute studies. This has aroused intense interest in the field of cardiac pacing. With concerted effort from the profession and the industry, leadless pacing may indeed become a sound idea.
Persistent Identifierhttp://hdl.handle.net/10722/200371
ISSN
2015 SCImago Journal Rankings: 0.614

 

DC FieldValueLanguage
dc.contributor.authorLee, KL-
dc.date.accessioned2014-08-19T03:55:42Z-
dc.date.available2014-08-19T03:55:42Z-
dc.date.issued2010-
dc.identifier.citationExpert review of cardiovascular therapy, 2010, v. 18 n. 2, p. 171-174-
dc.identifier.issn1477-9072-
dc.identifier.urihttp://hdl.handle.net/10722/200371-
dc.description.abstractCardiac pacemakers have been the standard therapy for patients with bradyarrhythmias for several decades. The pacing lead is an integral part of the system that serves as a conduit for delivery of energy pulses to stimulate the myocardium. However, it is also an Achilles tendon that directly causes most device complications both acutely during implant and chronically years afterwards. Both durability and optimization of stimulation site are important areas of improvement for manufacturers and implanters. Elimination of the pacing lead and utilization of other means for energy transfer is the only way to avoid lead complications and allow better choice of stimulation site. Leadless pacing with ultrasound-mediated energy has been demonstrated in animals and humans in acute studies. This has aroused intense interest in the field of cardiac pacing. With concerted effort from the profession and the industry, leadless pacing may indeed become a sound idea.-
dc.languageeng-
dc.publisherFuture Drugs Ltd.. The Journal's web site is located at http://www.future-drugs.com/publication.asp?publicationid=2-
dc.relation.ispartofExpert review of cardiovascular therapy-
dc.subjectCardiac resynchronization therapy-
dc.subjectHeart failure-
dc.subjectPacemaker-
dc.subjectUltrasound-
dc.titleIn the Wireless Era: Leadless Pacingen_US
dc.typeArticleen_US
dc.identifier.emailLee, LFK: klflee@hku.hk-
dc.identifier.emailLau, CP: mailcplau@hkucc.hku.hk.-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1586/erc.09.168-
dc.identifier.pmid20136603-
dc.identifier.scopuseid_2-s2.0-77951934901-
dc.identifier.hkuros700001823-
dc.identifier.volume18-
dc.identifier.issue2-
dc.identifier.spage171-
dc.identifier.epage174-
dc.publisher.placeLondon-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats